These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 18450356

  • 1. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F, Foquin A, Briot R, Delacour C, Denis J, Alonso A, Froment MT, Renault F, Lallement G, Masson P.
    Toxicology; 2008 Jun 27; 248(2-3):151-7. PubMed ID: 18450356
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies.
    Bloch-Shilderman E, Rabinovitz I, Egoz I, Raveh L, Allon N, Grauer E, Gilat E, Weissman BA.
    Toxicol Appl Pharmacol; 2008 Aug 15; 231(1):17-23. PubMed ID: 18485435
    [Abstract] [Full Text] [Related]

  • 5. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H, Hall C, Matar H, Dalton C, Chipman JK, Graham JS, Chilcott RP.
    J Appl Toxicol; 2018 Mar 15; 38(3):318-328. PubMed ID: 29023806
    [Abstract] [Full Text] [Related]

  • 6. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
    Graham JR, Wright BS, Rezk PE, Gordon RK, Sciuto AM, Nambiar MP.
    Inhal Toxicol; 2006 Jun 15; 18(7):493-500. PubMed ID: 16603480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
    Duysen EG, Li B, Xie W, Schopfer LM, Anderson RS, Broomfield CA, Lockridge O.
    J Pharmacol Exp Ther; 2001 Nov 15; 299(2):528-35. PubMed ID: 11602663
    [Abstract] [Full Text] [Related]

  • 9. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG, Hill I, Conley J, Sawyer TW, Caneva DC, Lundy PM.
    Mil Med; 2004 Nov 15; 169(11):856-62. PubMed ID: 15605929
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
    Reiter G, Müller S, Hill I, Weatherby K, Thiermann H, Worek F, Mikler J.
    Toxicol Lett; 2015 Jan 22; 232(2):438-48. PubMed ID: 25448275
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
    Bajgar J, Fusek J, Bartosova L, Jun D, Kuca K.
    J Appl Toxicol; 2006 Jan 22; 26(5):439-43. PubMed ID: 16915560
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
    Taysse L, Dorandeu F, Daulon S, Foquin A, Perrier N, Lallement G, Breton P.
    Hum Exp Toxicol; 2011 Jun 22; 30(6):491-8. PubMed ID: 20534641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
    Genovese RF, Sun W, Johnson CC, Ditargiani RC, Doctor BP, Saxena A.
    Basic Clin Pharmacol Toxicol; 2010 May 22; 106(5):428-34. PubMed ID: 20050840
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An animal model to study health effects during continuous low-dose exposure to the nerve agent VX.
    Rocksén D, Elfsmark D, Heldestad V, Wallgren K, Cassel G, Göransson Nyberg A.
    Toxicology; 2008 Aug 19; 250(1):32-8. PubMed ID: 18614271
    [Abstract] [Full Text] [Related]

  • 18. Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.
    Bloch-Shilderman E, Yacov G, Cohen L, Egoz I, Gutman H, Gez R, Rabinovitz I, Nili U.
    Arch Toxicol; 2019 May 19; 93(5):1365-1384. PubMed ID: 30729277
    [Abstract] [Full Text] [Related]

  • 19. Cardiorespiratory and neuromuscular effects of O-ethyl S--2-(diisopropylamino) ethyl- methylphosphonothioate (VX) in rats.
    Dube SN, Mazumder PK, Kumar D.
    Bull Environ Contam Toxicol; 1997 Aug 19; 59(2):246-53. PubMed ID: 9211695
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.